{"id":"https://openalex.org/W7212119596","doi":"https://doi.org/10.1080/13543784.2026.2729512","title":"Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products","display_name":"Innovative therapies under clinical development for ALS treatment. Part 2: biologics and natural products","alternate_titles":[],"publication_year":2026,"publication_date":"2026-09-12","ids":{"openalex":"https://openalex.org/W7212119596","doi":"https://doi.org/10.1080/13543784.2026.2729512","pmid":"https://pubmed.ncbi.nlm.nih.gov/42720979"},"language":"en","primary_location":{"id":"doi:10.1080/13543784.2026.2729512","doi":"https://doi.org/10.1080/13543784.2026.2729512","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2729512","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2729512?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7212119596"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2729512?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5143544764","display_name":"Chi-Chen Sarah Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165441096","display_name":"National Health Research Institutes","ror":"https://ror.org/02r6fpx29","country_code":"TW","type":"nonprofit","lineage":["https://openalex.org/I165441096"]},{"id":"https://openalex.org/I47519274","display_name":"Taipei Medical University","ror":"https://ror.org/05031qk94","country_code":"TW","type":"education","lineage":["https://openalex.org/I47519274"]}],"countries":["TW"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Chi-Chen Sarah Huang","raw_affiliation_strings":["Taipei Medical University and National Health Research Institutes, Taipei City, Taiwan","Taipei Medical University, New Taipei City, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taipei Medical University and National Health Research Institutes, Taipei City, Taiwan","institution_ids":["https://openalex.org/I165441096","https://openalex.org/I47519274"]},{"raw_affiliation_string":"Taipei Medical University, New Taipei City, Taiwan","institution_ids":["https://openalex.org/I47519274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088888916","display_name":"Cecilia Sanchez-Santos","orcid":"https://orcid.org/0009-0000-2411-7658","observed_orcids":["https://orcid.org/0009-0000-2411-7658"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210086696","display_name":"Biomedical Research Networking Center on Neurodegenerative Diseases","ror":"https://ror.org/00zca7903","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210086696"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210147680","display_name":"Centro de Investigaciones Biol\u00f3gicas Margarita Salas","ror":"https://ror.org/04advdf21","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210147680"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/validation","display_name":"Validation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Cecilia Sanchez-Santos","raw_affiliation_strings":["Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I4210147680"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I4210115082"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5128719349","display_name":"Loreto Mart\u00ednez-Gonz\u00e1lez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210086696","display_name":"Biomedical Research Networking Center on Neurodegenerative Diseases","ror":"https://ror.org/00zca7903","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210086696"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210147680","display_name":"Centro de Investigaciones Biol\u00f3gicas Margarita Salas","ror":"https://ror.org/04advdf21","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210147680"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/validation","display_name":"Validation"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Loreto Martinez-Gonzalez","raw_affiliation_strings":["Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I4210147680"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I4210115082"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060896107","display_name":"Carmen Gil","orcid":"https://orcid.org/0000-0002-3882-6081","observed_orcids":["https://orcid.org/0000-0002-3882-6081"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210086696","display_name":"Biomedical Research Networking Center on Neurodegenerative Diseases","ror":"https://ror.org/00zca7903","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210086696"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210147680","display_name":"Centro de Investigaciones Biol\u00f3gicas Margarita Salas","ror":"https://ror.org/04advdf21","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210147680"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/formal-analysis","display_name":"Formal analysis"},{"id":"https://openalex.org/contributor-roles/investigation","display_name":"Investigation"},{"id":"https://openalex.org/contributor-roles/resources","display_name":"Resources"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Carmen Gil","raw_affiliation_strings":["Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I4210147680"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I4210115082"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028669057","display_name":"Ana Mart\u00ednez","orcid":"https://orcid.org/0000-0002-2707-8110","observed_orcids":["https://orcid.org/0000-0002-2707-8110"]},"institutions":[{"id":"https://openalex.org/I2801357902","display_name":"Instituto de Salud Carlos III","ror":"https://ror.org/00ca2c886","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210086696","display_name":"Biomedical Research Networking Center on Neurodegenerative Diseases","ror":"https://ror.org/00zca7903","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210086696"]},{"id":"https://openalex.org/I4210115082","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red","ror":"https://ror.org/02g87qh62","country_code":"ES","type":"facility","lineage":["https://openalex.org/I2801357902","https://openalex.org/I4210115082","https://openalex.org/I4387152914"]},{"id":"https://openalex.org/I4210147680","display_name":"Centro de Investigaciones Biol\u00f3gicas Margarita Salas","ror":"https://ror.org/04advdf21","country_code":"ES","type":"facility","lineage":["https://openalex.org/I134820265","https://openalex.org/I4210147680"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[{"id":"https://openalex.org/contributor-roles/conceptualization","display_name":"Conceptualization"},{"id":"https://openalex.org/contributor-roles/data-curation","display_name":"Data curation"},{"id":"https://openalex.org/contributor-roles/funding-acquisition","display_name":"Funding acquisition"},{"id":"https://openalex.org/contributor-roles/resources","display_name":"Resources"},{"id":"https://openalex.org/contributor-roles/supervision","display_name":"Supervision"},{"id":"https://openalex.org/contributor-roles/writing-original-draft","display_name":"Writing \u2013 original draft"},{"id":"https://openalex.org/contributor-roles/writing-review-editing","display_name":"Writing \u2013 review & editing"}],"raw_author_name":"Ana Martinez","raw_affiliation_strings":["Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centro de Investigaciones Biologicas \u201cMargarita Salas\u201d-CSIC, Madrid, Spain","institution_ids":["https://openalex.org/I4210147680"]},{"raw_affiliation_string":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red en Enfermedades Neurodegenerativas, (CIBERNED), Instituto de Salud Carlos III, Avda, Madrid, Spain","institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I4210115082"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5028669057"],"corresponding_institution_ids":["https://openalex.org/I2801357902","https://openalex.org/I4210086696","https://openalex.org/I4210115082","https://openalex.org/I4210147680"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"35","issue":"10","first_page":"715","last_page":"733"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10855","display_name":"Amyotrophic Lateral Sclerosis Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12400","display_name":"Neurogenetic and Muscular Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amyotrophic-lateral-sclerosis","display_name":"amyotrophic lateral sclerosis","score":1.0},{"id":"https://openalex.org/keywords/biologics","display_name":"biologics","score":0.925000011920929},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.9980000257492065},{"id":"https://openalex.org/keywords/clinical-trial-pipeline","display_name":"clinical trial pipeline","score":0.7009999752044678},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.4449999928474426},{"id":"https://openalex.org/keywords/central-nervous-system-penetration","display_name":"CNS penetration","score":0.6320000290870667},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6970000267028809},{"id":"https://openalex.org/keywords/interpatient-variability","display_name":"interpatient variability","score":0.8119999766349792},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.9850000143051147},{"id":"https://openalex.org/keywords/artificial-intelligence-in-drug-development","display_name":"artificial intelligence in drug development","score":0.7799999713897705},{"id":"https://openalex.org/keywords/ethnopharmacology","display_name":"ethnopharmacology","score":0.9200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5127000212669373},{"id":"https://openalex.org/C2776608160","wikidata":"https://www.wikidata.org/wiki/Q4785462","display_name":"Natural (archaeology)","level":2,"score":0.4884999990463257},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.44020000100135803},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.38190001249313354},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.375},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.34060001373291016},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.29809999465942383},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2838999927043915},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2824999988079071},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.27320000529289246}],"mesh":[{"descriptor_ui":"D000076722","descriptor_name":"Drug Development","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000077558","descriptor_name":"Big Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000690","descriptor_name":"Amyotrophic Lateral Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000690","descriptor_name":"Amyotrophic Lateral Sclerosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/13543784.2026.2729512","doi":"https://doi.org/10.1080/13543784.2026.2729512","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2729512","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2729512?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:42720979","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42720979","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/13543784.2026.2729512","doi":"https://doi.org/10.1080/13543784.2026.2729512","is_oa":true,"landing_page_url":"https://doi.org/10.1080/13543784.2026.2729512","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/13543784.2026.2729512?needAccess=true","source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315062","display_name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","ror":null},{"id":"https://openalex.org/F4320335598","display_name":"Agencia Estatal de Investigaci\u00f3n","ror":"https://ror.org/003x0zc53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7212119596.pdf","grobid_xml":"https://content.openalex.org/works/W7212119596.grobid-xml"},"referenced_works_count":85,"referenced_works":["https://openalex.org/W1973382140","https://openalex.org/W1987782076","https://openalex.org/W2062238769","https://openalex.org/W2120469195","https://openalex.org/W2157194959","https://openalex.org/W2160029990","https://openalex.org/W2296135919","https://openalex.org/W2509084766","https://openalex.org/W2773307971","https://openalex.org/W2785185749","https://openalex.org/W2786608785","https://openalex.org/W2788288317","https://openalex.org/W2793144118","https://openalex.org/W2808422876","https://openalex.org/W2887319564","https://openalex.org/W2903636294","https://openalex.org/W2905561928","https://openalex.org/W2928956234","https://openalex.org/W2945080898","https://openalex.org/W2974194212","https://openalex.org/W2977662739","https://openalex.org/W3035761210","https://openalex.org/W3040840440","https://openalex.org/W3080361799","https://openalex.org/W3092560102","https://openalex.org/W3119952098","https://openalex.org/W3125845140","https://openalex.org/W3159078752","https://openalex.org/W3165008993","https://openalex.org/W4290830423","https://openalex.org/W4308590523","https://openalex.org/W4311510895","https://openalex.org/W4312045033","https://openalex.org/W4317868056","https://openalex.org/W4319825846","https://openalex.org/W4327681881","https://openalex.org/W4360850703","https://openalex.org/W4361301824","https://openalex.org/W4379056477","https://openalex.org/W4379057325","https://openalex.org/W4382344234","https://openalex.org/W4385661025","https://openalex.org/W4386818399","https://openalex.org/W4387770477","https://openalex.org/W4389609370","https://openalex.org/W4390805874","https://openalex.org/W4391566185","https://openalex.org/W4393104048","https://openalex.org/W4393118603","https://openalex.org/W4393280107","https://openalex.org/W4393581315","https://openalex.org/W4394600221","https://openalex.org/W4394601245","https://openalex.org/W4399216169","https://openalex.org/W4399422793","https://openalex.org/W4400362370","https://openalex.org/W4402254308","https://openalex.org/W4402581582","https://openalex.org/W4402862140","https://openalex.org/W4403208038","https://openalex.org/W4405663835","https://openalex.org/W4405923703","https://openalex.org/W4406325586","https://openalex.org/W4407152778","https://openalex.org/W4407547700","https://openalex.org/W4407625624","https://openalex.org/W4407625871","https://openalex.org/W4407986051","https://openalex.org/W4408070301","https://openalex.org/W4408247090","https://openalex.org/W4409334550","https://openalex.org/W4409415070","https://openalex.org/W4410514042","https://openalex.org/W4410593148","https://openalex.org/W4411192949","https://openalex.org/W4412115987","https://openalex.org/W4412490891","https://openalex.org/W4413641271","https://openalex.org/W4415532380","https://openalex.org/W4415721991","https://openalex.org/W4416775574","https://openalex.org/W7117313945","https://openalex.org/W7125382965","https://openalex.org/W7134115714","https://openalex.org/W7156896407"],"related_works":["https://openalex.org/W7156896407","https://openalex.org/W2592775972","https://openalex.org/W3115439136","https://openalex.org/W4393084799","https://openalex.org/W4319825846","https://openalex.org/W4296324533","https://openalex.org/W4322098205","https://openalex.org/W3101300126","https://openalex.org/W7203917531","https://openalex.org/W2120487028"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1],"clinical":[2,47,61,141],"trial":[3],"landscape":[4],"for":[5,74,146],"Amyotrophic":[6],"Lateral":[7],"Sclerosis":[8],"(ALS)":[9],"is":[10,51],"rapidly":[11],"expanding":[12],"despite":[13],"ongoing":[14],"translational":[15],"challenges.":[16],"Following":[17],"our":[18],"2022":[19,64],"analysis":[20],"and":[21,41,65,82,93,104,143,156,162,172],"as":[22,152,166,168],"a":[23,36],"continuation":[24],"of":[25,39,68,117,122],"Part":[26],"1,":[27],"which":[28],"focused":[29],"on":[30,53],"small":[31],"molecules,":[32],"this":[33,97,115],"review":[34],"provides":[35],"structured":[37],"overview":[38],"biologics":[40],"natural":[42],"products":[43],"in":[44,77,96,110],"the":[45,66,78,83,118,144],"ALS":[46,75,111],"pipeline.":[48],"Particular":[49],"emphasis":[50],"placed":[52],"candidates":[54],"that":[55],"entered,":[56],"advanced":[57],"through,":[58],"or":[59],"completed":[60],"evaluation":[62],"between":[63],"end":[67],"2025.":[69],"AREAS":[70],"COVERED:":[71],"Clinical":[72,87],"trials":[73],"registered":[76],"United":[79],"States":[80],"(ClinicalTrials.gov)":[81],"European":[84],"Union":[85],"(EU":[86],"Trials":[88],"Register/CTIS)":[89],"were":[90],"systematically":[91],"reviewed":[92],"are":[94,107],"summarized":[95],"report.":[98],"EXPERT":[99],"OPINION:":[100],"Modern":[101],"biotechnology,":[102],"ethnopharmacology,":[103],"classical":[105],"pharmacology":[106],"increasingly":[108],"converging":[109],"therapeutic":[112,164],"development,":[113,165],"making":[114],"one":[116],"most":[119],"active":[120],"areas":[121],"neurodegenerative":[123],"disease":[124],"research.":[125],"Nevertheless,":[126],"major":[127],"challenges":[128],"remain,":[129],"including":[130],"central":[131],"nervous":[132],"system":[133],"(CNS)":[134],"penetration,":[135],"long-term":[136],"safety,":[137],"interpatient":[138],"variability,":[139],"limited":[140],"evidence,":[142],"need":[145],"reliable":[147],"biomarkers.":[148],"Emerging":[149],"technologies,":[150],"such":[151],"big":[153],"data":[154],"analytics":[155],"artificial":[157],"intelligence,":[158],"may":[159],"help":[160],"accelerate":[161],"optimize":[163],"well":[167],"improve":[169],"patient":[170],"recruitment":[171],"stratification.":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7212119596","counts_by_year":[],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2026-09-11T00:00:00"}
